Blood-brain barrier impairment in acute optic neuritis evaluated by Gadolinium-DTPA enhanced MRI and CSF studies

European Journal of Neurology

Volumn 3, Issue 6, 1996, Pages 560-566

  Frederiksen, J L ^a,b   Larsson, H B W ^a   Christiansen, P ^a   Sellebjerg, F T ^a   Olesen, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Blood brain barrier; Gadolinium; IgG; Leucocytes; MRI; Multiple sclerosis; Oligoclonal bands; Optic neuritis

Indexed keywords

ALBUMIN; GADOLINIUM PENTETATE; IMMUNOGLOBULIN G;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CONTRAST ENHANCEMENT; FEMALE; HUMAN; IMMUNOGLOBULIN PRODUCTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PRIORITY JOURNAL;

EID: 0029960677     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.1996.tb00273.x     Document Type: Article

References (28)

1. Barkhof F, Frequin STFM, Hommes OR, Lamers K, Schaltens P, van Geel WJA and Valk J (1992) A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intraveneous methylprednisolone. Neurology, 42, 63-67.
2. Bastianello S, Pozzilli C, Bernardi S, Bozzao L, Fantozzi LM, Buttinelli C and Fieschi C (1990) Serial study of Gadolinium MRI enhancement in multiple sclerosis. Neurology, 40, 591-595.
3. Baum K, Nehrig C, Girke W, Bräu H and Schörner W (1990) Multiple sclerosis: relations between MRI and CT findings, cerebrospinal fluid parameters and clinical features. Clinical Neurology and Neurosurgery, 92, 49-56.
4. Baumhefner RW, Tourtellotte WW, Syndulko K, Waluch V, Ellison GW, Meyers LW, Cohen SN, Osborne M and Shapshak P (1990) Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis. Archives of Neurology, 47, 19-26.
5. Christiansen P, Frederiksen JL, Henriksen O and Larsson HBW (1992) Gd-DTPA-enhanced lesions in the brain in patients with acute optic neuritis. Acta Neurologica Scandinavian, 85, 141-146.
6. Fazekas F, Offenbacher H, Fuchs S, Schmidt R, Niederkorn K, Horner S and Lechner H (1988) Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology, 38, 1822-1825.
7. Frederiksen JL, Larsson HBW, Henriksen O and Olesen J (1989) Magnetic resonance imaging of the brain in acute isolated optic neuritis. Acta Neurologica Scandinavica, 80, 512-517.
8. Frederiksen JL, Larsson HBW and Olesen J (1992) Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic neuritis. Acta Neurologica Scandinavica 86, 317-322.
9. Kappos L, Pfeuffer B, Staedt D, Rohrbach E, Heun R, Haubitz I and Keil W (1988) Quantitative magnetic resonance imaging of the multiple sclerosis brain: localization rather than total volume of lesions correlates with cerebrospinal fluid IgG level and visual evoked response abnormalities. Annals of Neurology, 24, 169.
10. Kermode AG, Tofts PS, Thompson AJ, MacManus DG, Rudge P, Kendall BE, Kingsley DP, Moseley IF, duBoulay EP and McDonald WI (1990) Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology, 40, 229-235.
11. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33, 1444-1452.
12. 2 in the brain of patients with acute attack of multiple sclerosis. Magnetic Research in Medicine, 11, 337-348.
13. Larsson HBW, Stubgaard M, Frederiksen J, Jensen M, Henriksen O and Paulson OB (1990) Quantitation of blood-brain barrier defect by magnetic resonance imaging and Gadolinium-DTPA in patients with multiple sclerosis and brain tumours. Magnetic Research in Medicine, 16, 117-131.
14. Lassmann H, Suchanek G and Ozawa K (1994) Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Annals of Neurology, 36, 542-546.
15. Merandi SF, Kudryk BT, Murtagh FR and Arrington JA (1991) Contrast-enhanced MR imaging of optic nerve lesions in patients with acute optic neuritis. AJNR, 12, 923-926.
16. Miller DH, Rudge P, Johnson G, Kendall BE, McManus DG, Moseley IF, Barnes D and McDonald WI (1988) Serial Gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain, 111, 927-939.
17. Miller DH, Barkhof F and Nauta JJP (1993) Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain, 116, 1077-1094.
18. Müller FAJ, Hänny PE, Wichmann W, Fierz W and Dürsteier MR (1989) Cerebrospinal fluid immunoglobulins and multiple sclerosis. Correspondence with magnetic resonance imaging and visual evoked potential changes. Archives of Neurology, 46, 367-371.
19. Olsson T, Kostulas V and Link H (1984) Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labelling, and avidin-biotin amplification. Clinical Chemistry, 30, 1246-1249.
20. Pirttilä P and Nurmikko T (1995) CSF oligoclonal bands, MRI, and the diagnosis of multiple sclerosis. Acta Neurologica Scandinavica, 92, 468-471.
21. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH and Tourtellotte W (1983) New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Annals of Neurology, 13, 227-231.
22. Reiber H and Felgenhauer K (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous sytem. Clinica Chemica Acta, 37, 1153-1160.
23. Rolak LA, Beck RW, Paty DW, Tourtellotte WW, Whitaker JN and Rudick RA (1996), for the optic neuritis study group. Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial. Neurology, 46, 368-372.
24. Smith ME, Stone LA, Albert PS, Frank JA, Martin R, Armstrong M, Maloni H, McFarlin DE and McFarland HF (1993) Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Annals of Neurology, 33, 480-489.
25. Tas MW, Barkhof F, van Walderveen MAA, Polman CH, Hommes OR and Valk J. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. Am Journal of Neuroradiology, 16, 259-264.
26. Thompson AJ, Kermode AG, Wicks D, MacManus DG, Kendall BE, Kinglsey DPE and McDonald WI (1991) Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Annals of Neurology, 29, 53-62.
27. Thompson AJ, Miller D, Toul B, MacManus D, Moore S, Kingsley D, Kendall B, Feinstein A and McDonald WI (1992) Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration. Neurology, 42, 60-63.
28. Zeman AZJ, Kidd D, McLean BN, Kelly MA, Francis DA, Miller DH, Kendall BE, Rudge P, Thompson EJ and McDonald WI (1996) A study of oligoclonal band negative multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 60, 27-30.